Search results
Results from the WOW.Com Content Network
The vaccine produces a greater immune response than standard vaccine. According to the CDC, [1] "a study published in the New England Journal of Medicine [25] [in August, 2014] indicated that the high-dose vaccine was 24.2% more effective in preventing flu in adults 65 years of age and older relative to a standard-dose vaccine." The CDC ...
A Vaccine Information Statement (VIS) is a document designed by the Centers for Disease Control and Prevention (CDC) to provide information to a patient receiving a vaccine in the United States. The National Childhood Vaccine Injury Act requires that medical professionals provide a VIS to patients before receiving certain vaccinations.
During the worldwide Spanish flu pandemic of 1918, "Pharmacists tried everything they knew, everything they had ever heard of, from the ancient art of bleeding patients, to administering oxygen, to developing new vaccines and serums (chiefly against what we call Hemophilus influenzae – a name derived from the fact that it was originally considered the etiological agent – and several types ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate; Pages for logged out editors learn more
A vaccine that contains the A/Vietnam/1194/2004 (H5N1) flu strain. [30] Pumarix: A vaccine approved for medical use in the European Union in March 2011. [31] Seqirus/Audenz: A vaccine for adults that contains a killed flu strain called A/Astrakhan/3212/2020 (H5N8)-like strain. [32] Some older H5N1 vaccines for humans that have been licensed are:
Monovalent type A influenza vaccines are generally indicated during the pandemic or the flu for everyone without contraindications. According to the Advisory Committee on Immunization Practices (ACIP) under the Centre for Disease Control and Prevention (CDC), people aged above 10 are recommended to take one dose of H1N1 vaccine while those who are 6 months to 9 years old should be injected ...
In another randomized clinical trial conducted in 2014- 2015, the effectiveness of the recombinant vaccine and egg-based inactivated flu vaccine was compared in a population aged 50 or above. In contrast with the egg-based vaccine, the recombinant flu vaccine significantly reduced the risk of influenza-like illness by 30%. [13]
The Immunization Action Coalition (IAC) is an organization that distributes information about vaccines and the diseases they prevent. [2] In partnership with the Centers for Disease Control and Prevention (CDC), their headquarters is located in Saint Paul, Minnesota, with member coalitions in the United States and Canada.